Bousquet J. . .Highlights and recent developments in allergic diseases in EAACI journals. ” Clinical and Translational Allergy, 10(2020) : 1-11.
Iftikhar J. .2024 .Shifting perspectives: Diphenhydramine usage in anaphylaxis and urticaria across United States emergency departments. ” Annals of Allergy, Asthma and Immunology, 09(2024) : S11.
Charoo N.A. .2024 .Biowaiver monograph for immediaterelease solid oral dosage forms: Fexofenadine. ” Journal of Pharmaceutical Sciences, 02(2024) : 1201-1213.
Kapoor Y.,Kumar K. .2019 .Structural and clinical impact of anti-allergy agents: An overview. Bioorganic Chemistry, 103351 : .
Hailesilase G.G. .2024 .WHO/INRUD prescribing indicators with a focus on antibiotics utilization patterns at outpatient department of Adigrat General Hospital, Tigrai, Ethiopia: A retrospective cross-sectional study. ” Antimicrobial Resistance and Infection Control, 13(1) : .
Desai R.J. .2024 .Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED). ” BMJ, 384 : .
Bindel L.J.,Seifert R. . .” NaunynSchmiedeberg's Archives of Pharmacology. , 397(2024) : 1123-1135.
Cabral C.,JAC-Antimicrobial Resistance .2024 .Influences on use of antibiotics without prescription by the public in low- and middle-income countries: A systematic review and synthesis of qualitative evidence. , 6(5) : .
Schaller M.C. .2024 .Is the shift in treatment patterns toward new, more expensive drugs still driving the increase in pharmaceutical expenditure? A decomposition analysis of expenditure data in Sweden 1990-. Expert Review of Pharmacoeconomics and Outcomes Research, 2367445(2025) : 35-45.
Tang L. .2024 .A point prevalence survey and monitoring indicator research on the second batch of national key monitoring and rational use drugs. , 1416010 : .
.2023 .WHO model list of essential medicines. 23rd Edn, : .
Niëns L.M. . .Pharmaceutical pricing policies: A new methodology for comparing affordability of medicines.” Bulletin of the World Health Organization. , 90(2012) : 219-227.
Mendis S. . .The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. ” Bulletin of the World Health Organization, 85(2007) : 279-288.
Palafox B. .2021 .Inequality in access to medicines in lowand middle-income countries: A systematic review. International Journal for Equity in Health, 20(1) : .
.2019 .World Health Organization Regional Office for Europe. Improving access to quality essential medicines in Kyrgyzstan. , : .
Malaya E. .2024 .Medication adherence in allergic diseases and asthma in Kyrgyzstan: Financial reasons for poor uptake. , 1488665 : .
Tabyshova A. .2022 .Medication availability and economic barriers to adherence in COPD and asthma patients in Kyrgyzstan.”NPJ Primary Care Respiratory Medicine. , 32(1) : .
Stolbrink M. .2024 .Availability, cost and affordability of chronic respiratory disease medicines in low-income and middle-income countries. ” BMJ Global Health, 9 : .
Nations United .2024 .Office on Drugs and Crime. Study on the availability of controlled pharmaceutical drugs to treat severe pain in the Kyrgyz Republic. , : .
Wirtz V.J. .2017 .Essential medicines for universal health coverage.” The Lancet. , 6736(16) : 31599-9.
Koala D. .2021 .Factors influencing drug consumption and prediction methods: A review. ” arXiv, 2109 : 11779.
.2024 .. [24] CADAP. Systematisation report of the National Drug Policy Dialogue including Kyrgyzstan. EU-CADAP, : .
.2023 .Global antimicrobial resistance and use Surveillance System (GLASS) report 2023. , : .
Ivashchenko A.A. . .Drug utilization patterns of antihistamines in the Russian Federation using ATC/DDD methodology. International Journal of Risk and Safety in Medicine, 30(2019) : 123-131.
Tulegenova A. . .Drug utilization review of antihistamines in outpatient practice in Kazakhstan. Medical Journal of Kazakhstan, no. 4, (2018) : 45-50.
Rakhimova G.N. and N.K.,Yuldasheva G.N. and N.K. . .Pharmacotherapy patterns of allergic diseases in Uzbekistan: Focus on antihistamines. ” Bulletin of Medical Sciences (Uzbekistan), 3(2017) : 32-37.
Bousquet J. .2019 .Next-generation ARIA care pathways for allergic rhinitis and asthma multimorbidity. ” Allergy, 74(11) : 2084-2102.
Zhuravleva M.V. . .Drug utilization trends of systemic corticosteroids in the Russian Federation before and after the COVID-19 pandemic. Pharmacoepidemiology and Drug Safety, 32(2023) : 1021-1029.
Tulegenova A. . .Changes in systemic corticosteroid prescribing patterns in Kazakhstan in the post-COVID period. ” Central Asian Journal of Medicine, no. 2, (2023) : 45-52.
Elseviers M. .2023 .Drug utilization research in Eastern Europe: Post-pandemic shifts and regulatory challenges. , 1189021 : .
.2022 .Corticosteroids for COVID-19: Living guidance-post-pandemic considerations. , : .
Holloway K. .2021 .Surveillance of antimicrobial and corticosteroid use: Balancing access and rational use in lowand middle-income countries. ” WHO Drug Information, 35(2) : .